News

MedSafetyWeek November 2024 The MHRA’s ninth annual #MedSafetyWeek campaign runs from 4 to 10 November 2024. This year’s focus emphasises the critical role that Yellow Card reports play in preventing future harm and improving patient safety across the UK. Why Yellow Card Reporting Matters Every adverse drug reaction report submitted via the Yellow Card scheme […]

October 2024 MHRA Safety Communications The MHRA has published a summary of letters and notifications issued to healthcare professionals during October 2024 concerning medicines and medical devices. This monthly round-up ensures all clinical staff remain informed of important safety updates and product recalls. What You Need to Know The MHRA regularly communicates safety concerns, product […]

Key Safety Reminder for GLP-1 Receptor Agonists The MHRA has issued a reminder for healthcare professionals regarding glucagon-like peptide-1 receptor agonists (GLP-1RAs). This update emphasises the importance of patient counselling on potential side effects and highlights emerging concerns around misuse of these medications. What You Need to Know GLP-1RAs are widely prescribed for type 2 […]

New Guidance for Diabetes Equipment Users The MHRA has published updated guidance to help users of insulin pumps and continuous glucose monitoring (CGM) equipment report suspected adverse incidents and safety concerns through the Yellow Card scheme. What You Need to Know This guidance is aimed at: Users of insulin pumps and CGM devices Family members […]

Blood Pressure Monitoring Required for Bromocriptine Use The MHRA has issued a safety update following a Yellow Card report concerning bromocriptine prescribed for prevention or inhibition of post-partum physiological lactation. A safety review has concluded that blood pressure monitoring is essential when prescribing this medication. Key Points Bromocriptine carries a risk of blood pressure elevation […]

MHRA Drug Safety Update: September 2024 The MHRA has published a summary of letters and notifications issued to healthcare professionals during September 2024 concerning medicines and medical devices. This regular update ensures all clinical staff remain informed of important safety communications and product recalls. What You Need to Know The September 2024 alert package includes […]

August 2024 MHRA Safety Communications The MHRA has published a summary of letters and notifications issued to healthcare professionals during August 2024 concerning medicines and medical devices. This update consolidates recent safety communications to help you stay informed of regulatory actions affecting your practice. What You Need to Know The August 2024 communications package includes […]

Key Safety Update The MHRA has issued a precautionary safety alert regarding valproate use in men. A retrospective observational study has identified a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their children. What You Need to Know The alert applies to male […]

Yellow Card Biobank: Contributing to pharmacogenetic research The MHRA is inviting healthcare professionals and patients to contribute to an important research initiative exploring the genetic basis of side effects associated with two commonly prescribed medication classes. What is the Yellow Card Biobank? The Yellow Card Biobank is a collaborative study designed to investigate whether genetic […]

Important Safety Updates from the MHRA The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during July 2024. These communications cover a range of medicines and medical devices and include safety alerts, recalls, and important clinical guidance. What You Need to Know This monthly […]